The 68th ASH Annual Meeting and Exposition covers advancements in hematology, focusing on both malignant and non-malignant blood disorders, with a strong emphasis on treatment strategies, immunotherapy, gene editing, and emerging technologies.
Key Topics
Challenges in multiple myeloma treatment
Malignant hematology
Non-malignant hematology
Immunology - what the practicing hematologist needs to know
Management strategies for sickle cell disease
Inherited red cell disorders beyond hemoglobinopathies
Neutropenia
Multi-disciplinary hematologic disorders
Data science, computer vision and the hematology laboratory of the future
Aberrant transcriptional regulation in development and malignancies
Cellular memory and innate immune pathways during myeloid cell development and infection
Blood therapeutics in pandemics
Immune evasion and immunotherapy in myeloid malignancies
Next generation iron therapeutics
Lymphoid neoplasia
Advances in gene editing to treat genetic blood disorders
Ribosomes in hematopoiesis and disease
Novel findings in car-t cell therapies for hematologic malignancies
